Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus XR in African American Renal Transplant Recipients
NCT02956005Terminated
- Sponsor
- Georgetown University
- Start
- Sep 2016
- Primary completion
- Sep 2018
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tacrolimus in kidney transplantation, sponsored by Georgetown University. Primary endpoint: Calcineurin Inhibitor Toxicity at 1 year. Started Sep 2016; status: terminated.
02
Drugs
tacrolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT02956005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02956005.